Skip to main content
Improve  Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,954 across all filing types
Latest filing 2022-02-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于子公司获得欧盟质量管理体系(MDR)认证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Yangpu Medical Technology Co., Ltd. regarding its subsidiary obtaining the EU Quality Management System Certificate (MDR certification). It details the certification specifics, the impact on the company, and includes a statement from the board. The document is short (1585 characters) and does not contain any financial data, financial statements, or detailed financial analysis. It is not a report but an announcement about a certification achievement. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement about compliance and certification, not a financial or management report.
2022-02-08 Chinese
2021年年度业绩预告
Earnings Release Classification · 95% confidence The document is titled as a '2021 Annual Performance Forecast' (业绩预告) for the period January 1, 2021 to December 31, 2021. It provides estimated financial results including net profit and explanations for performance changes. It explicitly states that the data is preliminary, unaudited, and that detailed financial data will be disclosed in the 2021 annual financial report. The document is relatively short (1378 characters) and serves as a forecast or preliminary earnings guidance rather than a full financial report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. It is not a full Annual Report (10-K) or Interim Report (IR), nor is it an announcement of report publication (RPA). Therefore, the correct classification is Earnings Release (ER). FY 2021
2022-01-28 Chinese
关于子公司收到医疗器械注册变更文件的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a change in the registration and production mode of a medical device by a subsidiary. It details regulatory approval and changes in production address and mode but does not contain financial data, earnings, or management discussion. It is a regulatory announcement about operational changes, not a financial report or meeting material. The document length is short (1009 characters) and it is an announcement of a regulatory change, fitting best under Regulatory Filings (RNS).
2022-01-17 Chinese
关于阳普医疗科技股份有限公司公司债券的临时受托管理事务报告
Audit Report / Information Classification · 95% confidence The document is titled as a '临时受托管理事务报告' which translates to 'Interim Trustee Management Affairs Report' related to company bonds issued by 阳普医疗科技股份有限公司. It discusses bond issuance details, company name changes, bond management, and trustee responsibilities. The document is relatively short (2310 characters) and focuses on bond trustee management activities rather than full financial statements or audit results. It is not an annual or interim financial report, nor an earnings release or capital update. It is a specific report on bond trustee management, which aligns with the category of Audit Report / Information (AR) as it relates to regulatory and trustee reporting on bond issuance and management, excluding full annual reports. Therefore, the best fit is AR with high confidence. Q1 2022
2022-01-14 Chinese
关于变更医疗器械经营许可证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the change of a medical device business license, including details about the license number, legal representative, business scope, and addresses. It is a regulatory announcement about a license change and does not contain financial data, earnings, management changes, or voting results. The document is short (1175 characters) and is an official notice rather than a report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-01-10 Chinese
关于子公司完成医疗器械经营许可证变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Yangpu Medical Technology Co., Ltd. regarding the completion of a change in the medical device business license of its wholly-owned subsidiary. It details the updated license information, the expanded business scope, and the potential impact on the company. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to shareholder meetings or voting results. The document is an operational update about a subsidiary's license change, which fits best under general regulatory announcements that do not fit other specific categories. Given the short length (1271 characters) and the nature of the content, the most appropriate classification is Regulatory Filings (RNS).
2022-01-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.